Radius Health (RDUS) Tops Q2 EPS by 9c

Go back to Radius Health (RDUS) Tops Q2 EPS by 9c

Radius Health Announces Second Quarter 2020 Operating Results

August 10, 2020 8:16 AM EDT

TYMLOS® U.S. net sales of $50 million, with 22% year over year growth

Completion of enrollment in ATOM Phase 3 expected this week

Phase 3 Trials: wearABLe and EMERALD remain on track

Conference call scheduled for 8:30 a.m. ET today

WALTHAM, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Radius or the Company) (Nasdaq: RDUS), today reported its financial and operating results for the second quarter ended June 30, 2020 and provided a business update.

Completing... More